- Home
- RCKT vs PACB Comparison
RCKT vs PACB Comparison
Compare RCKT & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- PACB
- Stock Information
- Founded
- RCKT 1999
- PACB 2000
- Country
- RCKT United States
- PACB United States
- Employees
- RCKT N/A
- PACB N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- RCKT Health Care
- PACB Industrials
- Exchange
- RCKT Nasdaq
- PACB Nasdaq
- Market Cap
- RCKT 328.6M
- PACB 369.5M
- IPO Year
- RCKT N/A
- PACB 2010
- Fundamental
- Price
- RCKT $3.14
- PACB $1.50
- Analyst Decision
- RCKT Buy
- PACB Buy
- Analyst Count
- RCKT 13
- PACB 7
- Target Price
- RCKT $12.96
- PACB $1.90
- AVG Volume (30 Days)
- RCKT 2.2M
- PACB 6.2M
- Earning Date
- RCKT 11-06-2025
- PACB 11-06-2025
- Dividend Yield
- RCKT N/A
- PACB N/A
- EPS Growth
- RCKT N/A
- PACB N/A
- EPS
- RCKT N/A
- PACB N/A
- Revenue
- RCKT N/A
- PACB $156,110,000.00
- Revenue This Year
- RCKT N/A
- PACB $6.15
- Revenue Next Year
- RCKT $108.43
- PACB $15.68
- P/E Ratio
- RCKT N/A
- PACB N/A
- Revenue Growth
- RCKT N/A
- PACB N/A
- 52 Week Low
- RCKT $2.19
- PACB $0.85
- 52 Week High
- RCKT $18.89
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- RCKT 47.28
- PACB 67.25
- Support Level
- RCKT $3.15
- PACB $1.19
- Resistance Level
- RCKT $3.44
- PACB $1.34
- Average True Range (ATR)
- RCKT 0.18
- PACB 0.08
- MACD
- RCKT -0.00
- PACB 0.03
- Stochastic Oscillator
- RCKT 30.85
- PACB 87.50
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.